Epitalon side effects and risks

Reported side effects

• Sleep disruption, activation or anxiety: Anecdotal reports; no denominator or confirmed causality., moderate. Stop and seek review if symptoms persist or worsen. (source)
• Immune reaction to an injection: FDA identifies potential risk; no reliable human incidence., serious (source)
• Injection-related infection: No Epitalon specific incidence available., serious (source)
• Long-term cancer effects, unresolved: Mechanistic concern, not an established human adverse event rate., serious (source)

Stop and get help if

• Trouble breathing, throat or tongue swelling, or collapse: Stop use and call emergency services now.
• Fever with spreading injection-site redness, confusion or fast breathing: Seek urgent emergency care for possible severe infection.

Who should avoid it

• pregnant: No human pregnancy safety data. Precautionary exclusion.
• breastfeeding: Milk transfer and infant effects are unknown. Precautionary exclusion.
• tryingToConceive: Fertility effects and a safe washout interval are unknown. Precautionary exclusion.
• under18: Child safety is unestablished. Small reports do not establish a safe pediatric dose.
• kidneyDisease: Human clearance and dose adjustment in kidney disease are unknown.
• liverDisease: Human clearance and dose adjustment in liver disease are unknown.
• psychiatricCondition: Sleep disruption or agitation may worsen existing symptoms. Human psychiatric safety is untested.
• seizureDisorder: Seizure safety and interactions with seizure medicines have not been established.
• other: Avoid re-exposure after a serious allergic reaction.
• testedAthlete: Treat as prohibited under WADA S0. This applies the class rule; neither peptide is named.
• bleedingDisorder: Needle injections can cause bleeding or a hematoma. This is a procedure risk.
• activeCancer: Precautionary exclusion: telomere-maintenance effects in cancer cells raise concern. Human cancer risk is unknown.
• cancerHistory: Discuss with the oncology team. No human study establishes recurrence risk or long-term cancer safety.

Interactions

• Anticoagulants during intramuscular injections: IM injections can cause bruising or hematoma. A peptide-specific drug interaction has not been studied.
• Insulin and sulfonylureas: No human interaction study or dose-adjustment rule was found. Do not infer a need to change diabetes medicines.
• Melatonin and sleep medicines: Effects on sleep timing may overlap. No human combination or drug-absorption study establishes an interaction or adjustment rule.
• Other experimental peptides: No controlled combination safety evidence found. Sleep disruption is reported; multiple drugs obscure the cause.

Product quality risks

• A 2015 analysis identified Epitalon in two illegal preparations. Identity alone did not establish correct dose, sterility or safety.
• Unapproved injections can contain the wrong drug, the wrong amount, microbes or bacterial toxins called endotoxin.
• A research-only label, clear solution or high purity percentage does not establish injection quality.